My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.5896 -0.0027 (-0.46%)

Streaming Delayed Price Updated: 9:31 AM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Why Alteryx Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket ↗

February 10, 2023

Gainers

Via Benzinga

VistaGen Therapeutics's Return On Capital Employed Insights ↗

February 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 09, 2023

Via Benzinga

VistaGen Shares Plunge Amid Uncertainty Around Its Anxiety Trial ↗

February 08, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

February 08, 2023

Via Benzinga

Preview: VistaGen Therapeutics's Earnings ↗

February 06, 2023

Via Benzinga

VistaGen Therapeutics Earnings Perspective: Return On Capital Employed ↗

December 22, 2022

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 08, 2023

Via Benzinga

Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket ↗

February 08, 2023

Gainers PainReform Ltd. (NASDAQ: PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.

Via Benzinga

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023

January 19, 2023

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023

Via News Direct

Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023 ↗

January 17, 2023

In the race to create faster-acting, safer antidepressants, Vistagen (NASDAQ: VTGN) is starting the year strong as it gets ready to launch a Phase 1 Trial of its novel pherine nasal spray for Major...

Via Benzinga

Why AppTech Payments Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

January 31, 2023

Gainers

Via Benzinga

Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket ↗

December 29, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the...

Via Benzinga

Vistagen Strengthens Its Neurology Focused Pipeline With Pherin Pharma Acquisition ↗

December 21, 2022

Via Benzinga

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 19, 2022

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 16, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 06, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 29, 2022

Via Benzinga

Why Summit Therapeutics Shares Are Trading Higher By Over 82%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗

December 06, 2022

Gainers Summit Therapeutics Inc. (NASDAQ: SMMT) shares surged 82.2% to $1.4299 after the company announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 23, 2022

Via Benzinga

Earnings Outlook For VistaGen Therapeutics ↗

November 09, 2022

VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Thursday, 2022-11-10. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Earnings Scheduled For November 10, 2022 ↗

November 10, 2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

Via Benzinga

Why ECMOHO Is Trading Lower By 29%; Here Are 28 Stocks Moving Premarket ↗

September 21, 2022

Gainers Ampio Pharmaceuticals, Inc. (NYSE: AMPE) rose 17.8% to $0.0942 in pre-market trading after declining around 5% on Tuesday.

Via Benzinga

Why SciSparc Is Trading Higher By 68%, Here Are 48 Stocks Moving In Wednesday's Mid-Day Session ↗

September 14, 2022

Gainers Akerna Corp. (NASDAQ: KERN) shares rose 81.2% to $0.2355 after gaining 8% on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 12, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

Via InvestorPlace

Why Zumiez Is Trading Lower By 14%; Here Are 20 Stocks Moving Premarket ↗

September 09, 2022

Gainers Infobird Co., Ltd (NASDAQ: IFBD) rose 70.8% to $3.16 in pre-market trading after 1:5 reverse stock split takes effect.

Via Benzinga

Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday ↗

September 09, 2022

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.